These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25335648)

  • 1. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
    Fridberg DJ; Cao D; Grant JE; King AC
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial.
    King A; Cao D; Zhang L; Rueger SY
    Addiction; 2013 Oct; 108(10):1836-44. PubMed ID: 23714324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.
    King A; Cao D; Vanier C; Wilcox T
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1044-50. PubMed ID: 19302083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
    Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
    Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.
    Tidey JW; Monti PM; Rohsenow DJ; Gwaltney CJ; Miranda R; McGeary JE; MacKillop J; Swift RM; Abrams DB; Shiffman S; Paty JA
    Alcohol Clin Exp Res; 2008 Jan; 32(1):58-66. PubMed ID: 18028530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
    Anton RF; Latham PK; Voronin KE; Randall PK; Book SW; Hoffman M; Schacht JP
    Alcohol Clin Exp Res; 2018 Apr; 42(4):751-760. PubMed ID: 29431852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up.
    Robinson LE; Didier N; Thomas R; Vena A; King A
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):362-368. PubMed ID: 38752924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.
    Ray LA; Miranda R; Kahler CW; Leventhal AM; Monti PM; Swift R; Hutchison KE
    Psychopharmacology (Berl); 2007 Sep; 193(4):449-56. PubMed ID: 17484067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
    Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
    Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.
    King AC; Cao D; O'Malley SS; Kranzler HR; Cai X; deWit H; Matthews AK; Stachoviak RJ
    J Clin Psychopharmacol; 2012 Oct; 32(5):630-6. PubMed ID: 22926596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
    Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.
    Roche DJ; Bujarski S; Hartwell E; Green R; Ray LA
    Pharmacol Biochem Behav; 2015 Jul; 134():92-8. PubMed ID: 25933795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
    King A; de Wit H; Riley RC; Cao D; Niaura R; Hatsukami D
    Nicotine Tob Res; 2006 Oct; 8(5):671-82. PubMed ID: 17008194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
    Toll BA; White M; Wu R; Meandzija B; Jatlow P; Makuch R; O'Malley SS
    Drug Alcohol Depend; 2010 Oct; 111(3):200-6. PubMed ID: 20542391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.
    Roche DJO; Trela CJ; Argos M; Jasmine F; Kibriya MG; Ahsan H; King AC
    Alcohol Alcohol; 2019 Jan; 54(5):559-565. PubMed ID: 31206155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antagonists for smoking cessation.
    David S; Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2001; (3):CD003086. PubMed ID: 11687036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.